Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Tumori ; 71(4): 339-44, 1985 Aug 31.
Article in English | MEDLINE | ID: mdl-4049535

ABSTRACT

The authors report on 1,017 consecutive breast cancer cases without symptomatic metastases staged by means of chest X-ray (CXR), skeletal survey (BXR) and bone scintigraphy (BS). Occult metastases (DM) detection rate was 0.88%: 0.29% for lung and 0.59% for bone DM. The detection rate was correlated with clinical stage: 0.36% for stage I, 0.20% for stage II, 0.26% for stages I and II, and 2.77% for stage III cases. The sensitivity based on DM cases prevalent or surfacing within 6 months of follow-up was 0.30 for CXR, 0.22 for BXR and 0.55 for BS; specificity was 0.99, 0.98 and 0.90, respectively. The study confirms the possibility of early detection of DM with preoperative staging, but the extremely low detection rates in stage I and II cancers do not advise such a routine procedure. The higher detection rate of DM may suggest adoption of the routine staging procedure in stage III cancers. In these cases, although no evidence is available of a favorable prognostic impact of early detection and treatment of DM, an unnecessary mastectomy could be avoided in about 3% of cases in the presence of DM detected by the staging procedure.


Subject(s)
Breast Neoplasms/pathology , Age Factors , Aged , Bone and Bones/diagnostic imaging , Female , Humans , Middle Aged , Neoplasm Metastasis , Neoplasm Staging , Radiography, Thoracic , Radionuclide Imaging
2.
Tumori ; 69(6): 527-30, 1983 Dec 31.
Article in English | MEDLINE | ID: mdl-6665875

ABSTRACT

The authors report on 283 primary, non-metastatic, breast cancer cases consecutively referred after surgery and followed-up from a minimum of 10 months to a maximum of 3.5 years. All cases were studied according to the presence of estrogen receptors (ER). ER presence was correlated with age and menstrual status, with ER+ cases more frequent in older patients. No correlation was found between ER and nodal status. Prognosis was evaluated in terms of disease-free survival at 2 years (actuarial method). No correlation between ER and survival was evident for N- cases, whereas a better prognosis was recorded for ER+N+ patients compared to ER-N+, although the difference was not statistically significant. The observed results are compared with recent literature data and agree with other recent reports, which did not confirm the previously undiscussed statement regarding the prognostic role of ER determination. According to these studies and to the present study, the prognostic role of ER determination seems at least questionable and particularly the postoperative adjuvant treatment of ER-N- cases should be reconsidered.


Subject(s)
Breast Neoplasms/analysis , Estrogens/analysis , Receptors, Estrogen/analysis , Adult , Aged , Breast Neoplasms/diagnosis , Breast Neoplasms/mortality , Female , Follow-Up Studies , Humans , Lymphatic Metastasis , Menopause , Middle Aged , Postoperative Period , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...